d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis

• Status: Completed
• Trial end date: 2019-10-02
• Target enrollment: 0
• Participant gender: All

Summary

The Researchers are trying to determine if 68Ga-DOTATATE PET/CT imaging will have a similar accuracy as 18FDG PET/CT in diagnosing cardiac sarcoidosis and if it will be able to do so without the need for complex patient dietary preparation that is required with 18FDG PET/CT.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mayo Clinic
• Treatments: Fluorodeoxyglucose F18

Criteria

Inclusion Criteria:

• 18 years of age or older

• Referred for clinically indicated 18FDG PET/CT scan for cardiac sarcoidosis (CS)

Exclusion Criteria:

• Pregnant

• Unable or unwilling to give consent for 68Ga-DOTATATE PET/CT scan